greeksoup/ stock research

Aehr Test Systems (AEHR) Q4 FY2021 earnings: revenue $8 million, up 102.4% on the year

Aehr Test Systems (AEHR) reported revenue of $8 million for Q4 FY2021, the quarter ended 31 May 2021, up 102.4% on the same quarter a year earlier. Net income was $567,000, and diluted earnings per share $0.02. The figures are the company's own, from the 10-K it filed with the SEC on 27 August 2021.

Revenue$8 millionup 102.4%
Net income$567,000
Diluted EPS$0.02
QuarterQ4 FY2021ended 31 May 2021

The quarter, against the one before and a year earlier

LineQ4 FY2021Quarter beforeA year earlierChange on the year
Revenue7.6n/an/an/a
Cost of revenue4.1n/an/an/a
Gross profit3.5n/an/an/a
Gross margin46.3%n/an/a
Research and development1.0n/an/an/a
Selling, general and administrative1.9n/an/an/a
Operating income0.6n/an/an/a
Operating margin7.9%n/an/a
Pre-tax income0.6n/an/an/a
Income tax0.0n/an/an/a
Effective tax rate0.0%n/an/a
Net income0.6n/an/an/a
Net margin7.4%n/an/a
Diluted EPS$0.02n/an/an/a
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

LineQ4 FY2021Quarter beforeA year earlierChange on the year
Operating cash flow-0.2n/an/an/a
Capital expenditure0.0n/an/an/a
Free cash flow-0.2n/an/an/a
Free cash flow margin-2.8%n/an/a
Cash from investing-0.0n/an/an/a
Cash from financing0.1n/an/an/a
Depreciation and amortisation0.1n/an/an/a
Share-based compensation0.3n/an/an/a

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

LineQ4 FY2021Quarter beforeA year earlierChange on the year
Shareholders' equity11.4n/an/an/a
Non-controlling interest0.0n/an/an/a
Debt3.1n/an/an/a
Operating lease liabilities1.0n/an/an/a
Other liabilities6.1n/an/an/a
Total liabilities and equity21.7n/an/an/a
Fixed assets0.7n/an/an/a
Cash and equivalents4.6n/an/an/a
Receivables5.2n/an/an/a
Inventory8.8n/an/an/a
Other assets2.4n/an/an/a
Total assets21.7n/an/an/a

Questions

What was Aehr Test Systems' revenue in Q4 FY2021?

Aehr Test Systems (AEHR) reported revenue of $8 million for Q4 FY2021, the quarter ended 31 May 2021, up 102.4% on the same quarter a year earlier.

How much did Aehr Test Systems earn in Q4 FY2021?

Net income for Q4 FY2021 was $567,000, and diluted earnings per share $0.02.

When did Aehr Test Systems report Q4 FY2021 results?

Aehr Test Systems filed its 10-K for the quarter ended 31 May 2021 with the SEC on 27 August 2021.

Quarterly results, the last 20 quarters

Q4 FY2021Q1 FY2022 †Q2 FY2022Q3 FY2022Q4 FY2022Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026 *
Revenue7.65.69.615.320.310.714.817.222.320.621.47.613.113.518.314.111.09.910.318.8
Cost of revenue4.13.45.18.99.86.26.98.310.810.610.54.46.08.111.19.87.27.36.910.8
Gross profit3.52.34.56.410.54.57.98.911.510.011.03.27.15.47.24.33.72.53.48.0
Gross margin46%40%47%42%52%42%53%52%52%48%51%42%54%40%39%30%34%26%33%43%
R&D1.01.31.31.51.71.51.61.82.32.52.02.12.42.33.12.72.83.03.23.6
SG&A1.92.02.52.63.02.52.93.23.63.43.53.14.64.65.23.94.74.44.45.6
Operating income0.6-1.00.72.35.80.53.53.85.64.15.5-2.00.2-1.5-1.1-3.2-4.1-4.6-4.2-1.2
Operating margin8%-18%7%15%29%4%24%22%25%20%26%-27%1%-11%-6%-23%-37%-47%-41%-6%
Interest expensen/a0.0n/an/an/an/an/an/an/an/an/an/an/an/an/an/an/an/an/an/a
Pre-tax income0.60.70.82.35.80.63.74.16.14.76.1-1.50.8-1.2-0.9-3.0-2.8-4.4-4.0-0.5
Tax rate0%3%5%1%-2%2%0%0%0%0%0%n/a19%n/an/an/an/an/an/an/a
Net income0.60.70.72.25.80.63.74.16.14.76.1-1.50.7-1.0-0.6n/a-2.1-3.2-3.21.4
Net margin7%12%7%15%29%6%25%24%27%23%28%-19%5%-8%-4%n/a-19%-33%-31%7%
Diluted EPS$0.02$0.03$0.03$0.08$0.20$0.02$0.13$0.14$0.21$0.16$0.20-$0.05$0.02-$0.03-$0.02n/a-$0.07-$0.11-$0.10$0.04
Operating cash flow-0.21.93.3-2.9-0.85.5-0.2-1.15.93.9-0.5-2.82.4-5.9-1.6-2.3-0.3-1.2-3.71.8
Capital expenditure0.00.10.10.10.20.10.00.11.20.30.20.30.20.31.72.81.40.50.10.1
Free cash flow-0.21.83.3-3.0-1.05.4-0.2-1.24.73.6-0.7-3.12.2-6.2-3.3-5.1-1.7-1.6-3.81.7
Shares outstandingn/a24m27m27mn/a27m28m28m29m29mn/a29m30m30m30m30m30m31m31m32m
Filing10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-K for the period ended 31 May 2021, filed 27 August 2021: the filing.